Obinutuzumab: New Drug to Replace Rituximab? Medscape December 12, 2011 (San Diego, California) — For more than a decade now, rituximab (Rituxan, Genentech) has reigned supreme as the only drug of its kind — a monoclonal antibody specifically targeting the CD20 protein expressed on B cells. ... |
